stars 1 stars 2 stars 3

ONCOassist is a revolutionary new smart phone application for Oncology professionals. ONCOassist’s main value proposition is its suite of Decision Support tools. These tools put prognostic statistics into the hand of Oncology professionals at point of care. This will be used by them when they have to make a decision as to whether or not they should prescribe chemotherapy to patients. ONCOassist offers users three major advantages over traditional decision making methods: 1)ONCOassist gives users factual data which they can use to support their decisions. This enables them to make a more informed decision1. 2)ONCOassist is available in both smart phone app format and on the ODSS website; it can therefore be used anywhere in the hospital and without internet connection. 3)ONCOassist allows the patient become a partner in the decision making process, by giving the users easy to read statistics which can be explained to the patient, thus making them a well informed partner in the decision making process

ONCOassist Questions

The ONCOassist annual revenue was $400000 in 2026.

ONCOassist is based in London, Greater London.

The NAICS codes for ONCOassist are [513, 51, 5112, 511].

The SIC codes for ONCOassist are [73, 737].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users